Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMade Tech Regulatory News (MTEC)

Share Price Information for Made Tech (MTEC)

Share Price is delayed by 15 minutes
Get Live Data
39.25    0.00 (0.00%)
Bid:
38.50
Ask:
40.00
Spread: 1.50 (3.896%)
Market Cap: £58.60m
MTEC Live PriceLast checked at - London Stock Exchange

Intraday Made Tech Share Chart

Trading Update

2 May 2023 07:00

RNS Number : 9869X
Made Tech Group PLC
02 May 2023
Β 

2 May 2023

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Β 

MADE TECH GROUP PLC

("Made Tech", the "Group" or the "Company")

Β 

Trading Update

Β 

Made Tech, a leading provider of digital, data and technology services to the UK public sector, announces a trading update ahead of the full year ending 31 May 2023 ("FY23").

Β 

The Group has traded well so far during H2 FY23, with improved utilisation levels and continued momentum in our Sales Bookings1 and Contracted Backlog2. In particular, March 2023 delivered a very strong financial performance.

Β 

Recently, however, several of the Group's clients have moved the start date of work packages, which had previously been scheduled for April and May 2023, into FY24. As a result of this rephasing, which the Board believes is connected to the new public sector budget year, the Group now expects to report lower than anticipated revenue for FY23 of c. Β£40 million.

Β 

Gross Margin in H2 FY23 to date has improved, following the Group's strategic move away from using contractors and improvements in billed utilisation. The Group's fixed cost base, however, is set up to match previously anticipated revenue levels. The recent rephasing of activity has, accordingly, disproportionately impacted the expected adjusted EBITDA3 outcome for FY23, which is now estimated to be at least Β£1.5 million.

Β 

The Company's balance sheet remains strong with net cash, following continued investment in product development, of Β£7.9m as at 30 April 2023. The sales pipeline for our new IP product lines is very healthy: our first client is live and in implementation.

Β 

Rory MacDonald, Chief Executive Officer, commented:Β 

Β 

"We continue to make significant progress as a business, delivering substantial revenue growth and progress against our strategic priorities. We have our strongest ever Contracted Backlog at Β£61 million (30 November 2022: Β£47.8 million), an increase of 130% in Sales Bookings to a record Β£75 million (30 November 2022: Β£32.6 million), and a portfolio of new and existing clients, who are positive advocates for our business. Our new IP product lines are in their early stages but starting to build momentum, with two live products, whose sales pipelines are developing nicely.

Β 

Whilst recent events are very disappointing, the Group has a strong pipeline of new business opportunities, from both new and existing customers, for which it is very well positioned.Β 

Β 

I am as committed as ever to building a successful company which delivers significant long-term value to all stakeholders and remain confident in the prospects of the business."

Β 

1

Sales Bookings represent the total value of sales contracts awarded in the year, to be delivered in FY23-FY26

2

Contracted Backlog is the value of contracted revenue that has yet to be recognised

3

EBITDA has been adjusted for the exclusion of depreciation, amortisation, exceptional items and share based payment charges

Β 

Β Enquiries:

Β 

Made Tech Group plc

Rory MacDonald, CEO

Deborah Lovegrove, CFO

viaΒ Belvedere PR

Singer Capital Markets (Nominated Adviser & Broker)

Jennifer Boorer / Harry Gooden / Asha ChotaiΒ 

Tel: +44 20 7496 3000

Β 

Belvedere Communications (Financial PR)

Cat Valentine

Keeley Clarke

Email: madetech@belvederepr.com

Tel: +44 7715 769078

Tel: +44 7967 816525

Β 

About Made Tech:

Β 

Made Tech is a provider of digital, data and technology services to the UK public sector. Founded in 2008 and now with a headcount of over 460 and offices in four UK locations (London, Manchester, Bristol and Swansea), Made Tech provides services that enable central government, healthcare and local government organisations to digitally transform.

Β 

Made Tech's purpose is to "positively impact the future of society by improving public sector technology". To achieve this the company has four key strategic missions: Modernise legacy technology and working practices; Accelerate digital service and technology delivery; Drive better decisions through data and automation; and Enable technology and delivery skills to build better systems.

https://investors.madetech.com/

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTSSWEFFEDSEEI
12
Date   Source Headline
1st May 20266:14 pmRNSHolding(s) in Company
15th Apr 20267:00 amRNSMade Tech awarded £19m contract with the GDS
26th Feb 20267:00 amRNSAppointment of Chief Financial Officer
26th Feb 20267:00 amRNSInterim Results
10th Dec 20257:00 amRNSTrading Statement
25th Nov 20251:00 pmRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSGrant of LTIP and SAYE options
11th Nov 202512:22 pmRNSResult of AGM
27th Oct 20252:35 pmRNSHolding(s) in Company
16th Oct 20257:00 amRNSNotice of AGM
7th Oct 20257:00 amRNSDirectorate Change
24th Sep 20257:00 amRNSFinal Results
3rd Sep 20255:02 pmRNSHolding(s) in Company
5th Aug 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
17th Jul 20257:00 amRNSGrant of Awards / PDMR Dealings
26th Jun 20257:01 amRNSDirectorate Change
26th Jun 20257:00 amRNSFY25 Trading Update
8th May 20257:00 amRNS-RChange of Registered Office
7th Apr 20257:00 amRNSContract Wins
5th Feb 20257:00 amRNSHalf Year Results
23rd Jan 20257:00 amRNSNotice of Half Year Results
15th Jan 20257:00 amRNSNon-Executive Director Board Changes
26th Nov 20247:00 amRNSLaunch of 2024 SAYE Scheme & Grant of SAYE options
20th Nov 20242:11 pmRNSResult of AGM
20th Nov 20247:00 amRNSAGM Statement
21st Oct 20247:00 amRNSNotice of AGM & Posting of Annual Report
10th Oct 20247:00 amRNSDirector/PDMR Shareholding
30th Sep 20247:00 amRNSAudited Final Results 2024
16th Sep 20247:00 amRNSNew contract with the Department for Education
27th Jun 20247:00 amRNSFull Year Trading Update
1st May 20241:19 pmRNSDirector Share Purchase
23rd Apr 20243:47 pmRNSTR-1
22nd Apr 20247:00 amRNSMade Tech awarded £19.5m new contract with DLUHC
29th Feb 20247:00 amRNSTR-1
26th Feb 20249:09 amRNSHalf Year Results
26th Feb 20247:00 amRNSHalf Year Results
1st Feb 20247:00 amRNSTrading Update and Notice of Results
9th Jan 20247:00 amRNSAppointment of new CFO and Board Changes
17th Nov 20232:48 pmRNSDirector Share Purchase
30th Oct 20237:00 amRNSExercise of options and PDMR Dealing
26th Oct 20231:33 pmRNSResult of AGM
20th Sep 20233:55 pmRNSNotice of AGM and Posting of Annual Report 2023
13th Sep 20237:00 amRNSAudited Final Results 2023
6th Sep 20237:00 amRNSNotice of Results and Online Presentations
16th Aug 20235:26 pmRNSTR-1
25th Jul 20232:43 pmRNSGrant of LTIP Awards
5th Jul 20237:00 amRNSDirector Share Purchase
19th Jun 202310:03 amRNSTR-1
26th May 202312:38 pmRNSHolding(s) in Company
5th May 202312:56 pmRNSTR-1
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.